Skip to main content
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
2020 Year in Review - Lung Cancer
Lung Cancer
Metastatic Non–Small-Cell Lung Cancer
David Spigel, MD
Read More
Lung Cancer
Nonmetastatic Non–Small-Cell Lung Cancer
Geoff Oxnard, MD
Read More
Lung Cancer
Small-Cell Lung Cancer and Mesothelioma
David Spigel, MD
Read More
Lung Cancer
Metastatic Non–Small-Cell Lung Cancer with Targetable Mutations
Geoff Oxnard, MD
Read More
Lung Cancer
Durvalumab in Combination with Chemotherapy as First-Line Treatment for Extensive-Stage SCLC (CASPIAN Data)
Read More
Lung Cancer
Platinum Doublet Chemotherapy plus Pembrolizumab for Patients with SCLC: KEYNOTE-604
Read More
Lung Cancer
Cediranib Combined with Olaparib in Patients with Platinum-Pretreated SCLC
Read More
Lung Cancer
Lurbinectedin for Second-Line Treatment of Patients with Metastatic SCLC
Read More
Lung Cancer
Real-World Data for Nivolumab in Patients with Malignant Mesothelioma
Read More
Lung Cancer
Trastuzumab Deruxtecan in Patients with HER2-Mutated Advanced NSCLC
Read More
1
2
3
Page 1 of 3
Results 1 - 10 of 24